A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

The Chief Medical Officer and Director of Global Healthcare and Non-profits at Amazon Web Services, Dr Rowland Illing, has ...

An international research collaboration led by Rutgers University-New Brunswick scientists that examined microscopic blobs of ...

Precise mapping of a patient’s brain can enable a wider range of treatments, writes DR ROWLAND ILLING, chief medical officer ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

Clinical trials show stem cell therapies for Parkinson's disease are safe, potentially offering more effective treatment with fewer side effects.

THURSDAY, April 17, 2025 (HealthDay News) -- Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinson’s disease, a new study says.

April is Parkinson’s Disease Awareness Month. Studies show that every six minutes, someone will be diagnosed with Parkinson’s Disease. “It’s incredibly important ...

Apr. 14, 2025 — A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool ...

For the third year, the Michael J. Fox Foundation organized a concert benefit at Belmont University's Fisher Center for ...

Former Newsight presenter Jeremy Paxman has sparked concerns after being absent from podcast recordings and a World Parkinson ...